Literature DB >> 23430001

Catheter tract recurrence after percutaneous biliary drainage for hilar cholangiocarcinoma.

Hiroshi Kawakami.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23430001     DOI： 10.1007/s00268-013-1955-3

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  5 in total

1.  Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma.

Authors:  Y Takahashi; M Nagino; H Nishio; T Ebata; T Igami; Y Nimura
Journal:  Br J Surg       Date:  2010-08-26       Impact factor: 6.939

2.  Reappraisal of percutaneous transhepatic biliary drainage tract recurrence after resection of perihilar bile duct cancer.

Authors:  Shin Hwang; Gi-Won Song; Tae-Yong Ha; Young-Joo Lee; Ki-Hun Kim; Chul-Soo Ahn; Kyu-Bo Sung; Gi-Young Ko; Myeong-Hwan Kim; Sung-Koo Lee; Deok-Bog Moon; Dong-Hwang Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

3.  Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications.

Authors:  Hiroki Kawashima; Akihiro Itoh; Eizaburo Ohno; Yuya Itoh; Tomoki Ebata; Masato Nagino; Hidemi Goto; Yoshiki Hirooka
Journal:  Ann Surg       Date:  2013-01       Impact factor: 12.969

4.  Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma.

Authors:  Hiroshi Kawakami; Masaki Kuwatani; Manabu Onodera; Shin Haba; Kazunori Eto; Nobuyuki Ehira; Hiroaki Yamato; Taiki Kudo; Eiichi Tanaka; Satoshi Hirano; Satoshi Kondo; Masahiro Asaka
Journal:  J Gastroenterol       Date:  2010-08-11       Impact factor: 7.527

5.  Catheter tract recurrence after percutaneous biliary drainage for hilar cholangiocarcinoma.

Authors:  Mee Joo Kang; Yun-Suk Choi; Jin-Young Jang; In Woong Han; Sun-Whe Kim
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.